Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Charles Morrison
FHI 360
Washington, DC
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
99
TOTAL CITATIONS
1
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial
Number of pages: 39
Posted: 11 Jun 2021
Nelly R. Mugo
,
Randy M. Stalter
,
Renee Heffron
,
Helen Rees
,
Caitlin W. Scoville
, Charles Morrison,
Athena P. Kourtis
,
Elizabeth Bukusi
,
Malgorzata E. Beksinska
,
Neena Philip
,
Ivana Beesham
,
Jen Deese
,
Vinodh Edward
,
Deborah Donnell
and
Jared M. Baeten
University of Washington - Department of Global Health, University of Washington - Department of Global Health, University of Washington - Department of Global Health, University of the Witwatersrand - Reproductive Health and HIV Research Unit (RHRU), University of Washington - Department of Global Health, FHI 360, Government of the United States of America - Division of HIV Prevention, Kenya Medical Research Institute (KEMRI) - Center for Clinical Research, University of the Witwatersrand - MatCH Research Unit (MRU), Columbia University - ICAP, University of the Witwatersrand - MatCH Research Unit (MRU), Kenya Medical Research Institute (KEMRI) - Center for Clinical Research, Aurum Institute, Fred Hutchinson Cancer Research Center and University of Washington - Department of Global Health
Downloads
57
(1,000,027)
View PDF
Download
Abstract:
Herpes simplex virus type 2 (HSV-2), HIV, contraception, women, Africa
2.
Weight Change Among Women Using Intramuscular Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: Findings from a Randomised, Multicentre, Open-Label Trial
Number of pages: 22
Posted: 10 Dec 2020
Malgorzata E. Beksinska
,
Rodal Issema
,
Ivana Beesham
,
Tharnija Lalbahadur
,
Katherine Thomas
, Charles Morrison,
George Justus Hofmeyr
,
Petrus Steyn
,
Nelly R. Mugo
,
Thesla Palanee-Phillips
,
Khatija Ahmed
,
Gonasagrie Nair
,
Jared M. Baeten
and
Jennifer Smit
University of the Witwatersrand - MatCH Research Unit (MRU), University of Washington - Department of Global Health, University of the Witwatersrand - MatCH Research Unit (MRU), University of the Witwatersrand - MatCH Research Unit (MRU), University of Washington - Department of Global Health, FHI 360, University of the Witwatersrand/Fort Hare - Effective Care Research Unit, World Health Organization - UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), University of Washington - Department of Global Health, University of the Witwatersrand - Wits Reproductive Health and HIV Institute (Wits RHI), Setshaba Research Centre, Emavundleni Research Centre, University of Washington - Department of Global Health and University of the Witwatersrand - MatCH Research Unit (MRU)
Downloads
42
(1,157,785)
Citation
1
View PDF
Download
Abstract:
Feedback